Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-19

FDA Approved: EPTIFIBATIDE — Supplemental Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for the generic drug eptifibatide from Slate Run Pharmaceuticals, LLC, finalizing the regulatory action for this supplem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

SUPPL AP for EPTIFIBATIDE (EPTIFIBATIDE)